Business Wire

MI-EATON-VEHICLE-GROUP

21.4.2022 12:32:13 CEST | Business Wire | Press release

Share
Eaton’s Vehicle Group Facilities Reducing Environmental Impact With New Technologies and Systems

Power management company Eaton today announced its Vehicle Group has certified 88% of its global facilities as “zero-waste-to-landfill” (ZWTL), having cut the amount of waste going into landfills by 55% since 2019. Eaton defines ZWTL as consistently achieving a landfill waste diversion rate of 98% through reuse, composting, recycling or incineration, but only if the heat generated by incineration was collected and used to create more energy than what was used in the incineration process.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220421005050/en/

“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities, leveraging technology to improve energy efficiency, minimize environmental impact and bring us closer to a carbon-free future,” said Sunil Bhandari, vice president, Global Operations, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”

To reduce waste, the Vehicle Group is focused on four primary areas: reuse, recycle, waste to energy and waste to landfill.

Separating swarf from water and recycling keeps it from landfill

One of the key projects in these efforts is the Vehicle Group’s swarf grinding project, which is in the process of being implemented at all its global sites that perform grinding operations.

Swarf is a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media. Swarf is one of the most difficult waste streams to recycle, but the Vehicle Group has made great strides in diverting swarf waste from landfills.

Through vendor partnerships, the Vehicle Group deploys a mobile centrifuge process that separates the materials. The fluid then is reused in manufacturing processes, and the metal particles are recycled, resulting in cost savings. A swarf recycling trial in 2019 diverted 500 tons from the landfill, and work is ongoing to expand this solution to expedite ZWTL progress.

The Vehicle Group is finding reuse opportunities to eliminate sludge created during the plating process by recycling the metal content, which eliminates the need for disposal into a landfill. It is also working to develop a more efficient filtering process to remove sludge and reuse the water for further plating.

Additionally, significant progress is being made in the segregation of general trash. Trash is typically created from a lack of knowledge of recycling opportunities and the use of unrecyclable materials. In an effort to prevent paper, metal and recyclable plastics from going into the trash, the Vehicle Group is working to improve education around recycling opportunities and procedures. Along these same lines, the Vehicle Group is ensuring all packaging it uses is recyclable and is encouraging its suppliers to do the same.

“For these efforts to realize their full potential, we are educating our teams on correct recycling methods, and we are asking for input on how to identify issues and new areas of opportunity,” Bhandari said.

Water conservation efforts making a significant impact at global sites

Implementing several innovative initiatives, the Vehicle Group has lowered water consumption at its global sites by 14% since 2019, putting it well on its way to achieving its 2030 zero water discharge target.

To reduce water consumption and mitigate pollutants, the Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies at several of its facilities. The systems treat and reuse water for industrial purposes. Some facilities are also managing stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion and planting native florae that don’t require watering. Additionally, automatic flow-sensor faucets are being installed at Vehicle Group global facilities to enable the reuse of chiller water used during daily operations.

Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.

Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power — today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.

Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com . Follow us on Twitter and LinkedIn.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye